Osheru - Ziplyft

Osheru - Ziplyft Completes $4.7M Funding Round for Innovative Blepharoplasty Device Learn more & get our take ?? https://lnkd.in/g2vt8sBW “This $4.7 million funding marks a pivotal moment for Osheru. It demonstrates the strong confidence in Ziplyft from both the medical community and investors, validating our vision to revolutionize blepharoplasty with cutting-edge technology.” — Dr. Patricia Buehler, MD, MPH, CEO at Osheru “Joining Osheru to launch Ziplyft is an exciting opportunity. This innovative technology addresses key challenges in blepharoplasty, promising improved outcomes for patients and enhanced capabilities for surgeons. I’m eager to drive its growth and advance the field of eyelid surgery.” — John Garland, Chief Commercial Officer (CCO) at Osheru “Despite the challenging fundraising environment for startups today, Osheru’s success in securing this funding round highlights their perseverance and the compelling value proposition of Ziplyft.” — Skip Rung, President at Oregon Nanoscience and Microtechnologies Institute (ONAMI) #funding #blepharoplasty #SoHCNews

Osheru - Ziplyft, a medical device company based in Bend, Oregon, has raised $4.7 million in seed funding. The investment round was led by individual investors and family offices, with notable participation from Nike Co-Founder Phil Knight. Other investors included the Oregon ToughTech BreakThrough Fund, managed by ONAMI for Business Oregon, and SOPHINCAP, the Corporate Venture Fund of Laboratorios Sophia. Osheru plans to use this funding to accelerate the development and commercialization of its device, which is designed for blepharoplasty surgery, a procedure to repair droopy eyelids. This investment suggests a growing interest in specialized medical devices and highlights Osheru's potential to innovate in the field of ophthalmic surgery. https://lnkd.in/dYZyySD5

BIG NEWS for Osheru - Ziplyft ! Today, Osheru announced the successful completion of a $4.7 million seed funding round, spearheaded by prominent investors including Nike Co-Founder Phil Knight and Oregon ToughTech BreakThrough Fund. This funding will accelerate the development and commercialization of their groundbreaking #Ziplyft device, poised to transform #blepharoplasty procedures. Additionally, Osheru welcomes John Garland as Chief Commercial Officer, bringing decades of expertise in medical device commercialization. With commercialization set for 2025, Osheru is set to redefine eyelid surgery, enhancing outcomes for both patients and surgeons. Congratulations Patricia Buehler, MD, MPH and team! To read the full press release click here https://lnkd.in/e2p2HFHj

?? Exciting News! Osheru has secured a $4.7 million fundraise to advance the revolutionary Ziplyft Device, enhancing eyelid surgery for both patients and surgeons. The oversubscribed funding round underscores investor confidence in Osheru's transformative approach to eyelid surgery. #Innovation #Ophthalmology #Investment #Eyecelorator #blepharoplasty

In the article, “Creating a medical device — from idea to use in patients,” Patricia Buehler, MD, MPH, Osheru - Ziplyft, Infocus Eye Care, shares the steps that she and her team took to take their device from idea to use. Read the full article at our website https://ow.ly/xMSJ50RkJ1P. #ziplyft #ophthalmologist #ophthalmology #youngophthalmologists #eyecare

If there is one thing we are passionate about at iDocSocial is physician led #projects. This month at American Society of Cataract and Refractive Surgery (ASCRS) we had a chance to sit with Patricia Buehler, MD, MPH, , Founder and CEO of Osheru - Ziplyft. Osheru is a medical device company looking to innovate eyelid surgery with #ziplyft. This year at Eyecelerator, Ziplyft won Best New Technology Company making Osheru the first company to win at Eyecelerator two years in a row! We are so excited for whats to come from the Osheru team. We are rooting for you! To learn more about Ziplyft listen to this video and visit ziplyft.com #blepharoplasty #eyelidsurgery #ophthalmology #ascrs #eyecare #osheru #eyecelerator